Erythromycin Impurity 5 | CAS 58781-38-7 - Request Quote
Erythromycin Impurity 5
| SZ CAT No: | SZ-E006057 |
| CAS No | 58781-38-7 |
| Mol.F. | C38H63NO13 |
| Mol.Wt. | 741.9 |
| Inv. Status | Synthesis on demand |
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Erythromycin Impurity 5 is chemically . Erythromycin Impurity 5 is supplied with detailed characterization data compliant with regulatory guideline. Erythromycin Impurity 5 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Erythromycin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 58781-38-7
Purchase 58781-38-7
Order 58781-38-7
Enquire 58781-38-7
price of 58781-38-7
58781-38-7 Supplier
58781-38-7 Manufacturer
58781-38-7 Exporter
buy high quality Erythromycin Impurity 5
Purchase Erythromycin Impurity 5
Erythromycin Impurity 5 suppliers
Erythromycin Impurity 5 manufacturers
Erythromycin Impurity 5 price
Order Erythromycin Impurity 5
Enquire Erythromycin Impurity 5
Erythromycin Impurity 5 cost
Erythromycin Impurity 5 Supplier
Erythromycin Impurity 5 Distributor
Erythromycin Impurity 5 for Method Validation
Erythromycin Reference Standard
Erythromycin Impurity 5 for ANDA Filing
Erythromycin Impurity 5 for Forced Degradation Studies
Erythromycin Impurity 5 Identification Standards
Erythromycin Impurity 5 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.